Literature DB >> 21651721

Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practice.

Claus Garbe1, Thomas K Eigentler, Jürgen Bauer, Norbert Blödorn-Schlicht, Falko Fend, Markus Hantschke, Peter Kurschat, Heinz Kutzner, Dieter Metze, Harald Pressler, Michael Reusch, Martin Röcken, Rudolf Stadler, Michael Tronnier, Amir Yazdi, Gisela Metzler.   

Abstract

BACKGROUND: TNM classifications are the basis for diagnostic and therapeutic procedures in oncology. Histopathological reports have to enable a proper indexing of tumor specific findings into recent classifications.
METHODS: A systematic review of the literature was performed to identify reports dealing with the assessment of mitotic rate and the processing and evaluation of sentinel node biopsies in malignant melanoma. On the basis of this review an expert panel of dermatopathologists and general pathologists discussed and agreed recommendations for general practice.
RESULTS: Following recommendations were agreed with a broad consensus (93-100 % agreement): The determination of the mitotic rate in primary melanoma is performed on HE slides. The evaluation of an area of 1 mm(2) is sufficient. Only dermal mitoses are considered. The counted number of mitoses is provided as an integer value. The mitotic rate shall be determined in primary melanomas of ≤1.00 mm vertical tumor thickness according to the hot-spot method and provided as an integer value in relation to an area of 1 mm(2) . The determination of the mitotic rate in the case of thicker primary melanomas is desirable. In general, for the evaluation of each sentinel lymph node, 4 slides should be prepared. For diagnostic purposes, immunohistochemistry (preferably with antibodies against S100ß, Melan A and HMB-45) should be performed in addition to HE staining. The pathology report should provide information about micro-metastases and their longest extension (one-tenth of a millimeter).
CONCLUSIONS: These recommendations are suitable for standardizing the histopathological diagnosis of malignant melanoma and for providing a common basis for clinical decisions and scientific research.
© The Authors • Journal compilation © Blackwell Verlag GmbH, Berlin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651721     DOI: 10.1111/j.1610-0387.2011.07714.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  13 in total

1.  Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.

Authors:  Torsten Hinz; Hojjat Ahmadzadehfar; Anja Wierzbicki; Tobias Höller; Jörg Wenzel; Hans-Jürgen Biersack; Thomas Bieber; Monika-H Schmid-Wendtner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12-08       Impact factor: 9.236

2.  Improving Melanoma Path Reports: the Importance of Histopathological Parameters in Diagnosis of Cutaneous Melanoma.

Authors:  Alina Mariana Avram; Olga Dana Simionescu; Mariana Costache; Mariana Grigore
Journal:  Maedica (Buchar)       Date:  2015-09

3.  [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].

Authors:  C Rose
Journal:  Pathologe       Date:  2017-02       Impact factor: 1.011

Review 4.  Predicting the outcome of melanoma: can we tell the future of a patient's melanoma?

Authors:  Oriol Yélamos; Pedram Gerami
Journal:  Melanoma Manag       Date:  2015-08-10

Review 5.  [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].

Authors:  C Rose
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

6.  Cultivation-dependent plasticity of melanoma phenotype.

Authors:  Ondřej Kodet; Barbora Dvořánková; Eliška Krejčí; Pavol Szabo; Petr Dvořák; Jiří Štork; Ivana Krajsová; Pavel Dundr; Karel Smetana; Lukáš Lacina
Journal:  Tumour Biol       Date:  2013-06-12

7.  Host kinin B1 receptor plays a protective role against melanoma progression.

Authors:  Andrea G Maria; Patrícia Dillenburg-Pilla; Rosana I Reis; Elaine M Floriano; Cristiane Tefé-Silva; Simone G Ramos; João B Pesquero; Clara Nahmias; Claudio M Costa-Neto
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

8.  Malignant melanoma.

Authors:  Aída Ortega Candil; Cristina Rodríguez Rey; José Luis Carreras Delgado
Journal:  ISRN Dermatol       Date:  2012-12-04

9.  Genetic heterogeneity of breast cancer metastasis may be related to miR-21 regulation of TIMP-3 in translation.

Authors:  Jianyi Li; Yang Zhang; Wenhai Zhang; Shi Jia; Rui Tian; Ye Kang; Yan Ma; Dan Li
Journal:  Int J Surg Oncol       Date:  2013-07-10

10.  The relationship between mitotic rate and depth of invasion in biopsies of malignant melanoma.

Authors:  Hamid Reza Ghasemi Basir; Pedram Alirezaei; Sara Ahovan; Abbas Moradi
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.